Zu den Inhalten springen
Marien Hospital Herne
St. Elisabeth Gruppe
HomeHome
Klinik für Urologie

ImVigor 011/BO42843

A Phase III, Double-Blind, Multicenter, Randomized Study of Atezolizumab (Anti-PDL1 Antibody) Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy

© Marien Hospital Herne | Impressum | . Datenschutz | . Datenschutz­einstellungen anpassen.